Observations placeholder
Kaletra
Identifier
005605
Type of Spiritual Experience
Background
A description of the experience
Lopinavir / Kaletra
is an antiretroviral of the protease inhibitor class. It is used as a fixed-dose combination with another protease inhibitor, ritonavir, under the trade names Kaletra and Aluvia.
On Jan, 02, 2017 16,957 people reported to have side effects when taking Kaletra. Among them, 44 people (0.26%) have Hallucination
On Jan, 31, 2017 16,957 people reported to have side effects when taking Kaletra. Among them, 23 people (0.14%) have Hallucination, Auditory